The Surgery franchise is simplifying operations by exiting product lines and optimizing its site network, with an estimated total cost of $0.9B to $1.0B. This creates needs for operational consulting, supply chain optimization, and IT systems consolidation to manage the transition, which is expected to be completed by the end of fiscal 2026.
Filing excerpt
In fiscal 2025, the company initiated a restructuring program of its Surgery franchise within the MedTech segment to simplify and focus operations by exiting certain non-strategic product lines and optimize select sites across the network.
What this signalsFilings often name leadership changes, deals and spending plans.
sec-10qdivestitureGet every 10-Q signal for Johnson & Johnson and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Johnson & Johnson this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/ae191697-f6ce-4f8c-91c4-6ff3366c1fcf returns this record as JSON. POST /v1/companies/enrich returns every signal for jnj.com.
{
"signal_id": "ae191697-f6ce-4f8c-91c4-6ff3366c1fcf",
"signal_type": "sec-10q",
"signal_subtype": "divestiture",
"detected_at": "2026-04-28T10:05:23.332+00:00",
"company": {
"name": "Johnson & Johnson",
"domain": "jnj.com"
},
"data": {
"detail": "The Surgery franchise is simplifying operations by exiting product lines and optimizing its site network, with an estimated total cost of $0.9B to $1.0B. This creates needs for operational consulting, supply chain optimization, and IT systems consolidation to manage the transition, which is expected to be completed by the end of fiscal 2026.",
"metrics": {
"timeframe": "current_year",
"dollar_context": "Midpoint of estimated total cost for the Surgery franchise restructuring program.",
"dollar_millions": 950
},
"summary": "J&J's MedTech segment is undergoing a $1B restructuring, exiting non-strategic surgery product lines.",
"excerpts": "In fiscal 2025, the company initiated a restructuring program of its Surgery franchise within the MedTech segment to simplify and focus operations by exiting certain non-strategic product lines and optimize select sites across the network.",
"relevance": 0.9,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/200406/000020040626000087/jnj-20260329.htm",
"filing_date": "2026-04-22",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "03/29",
"sales_relevance": "Carve-out support needed",
"signal_category": "strategic"
}
}
curl https://signals.autobound.ai/v1/signals/ae191697-f6ce-4f8c-91c4-6ff3366c1fcf \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"jnj.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.